PRISTINE Study with SELUTION SLR Sirolimus Drug Eluting Balloon: First Two Patients Enrolled
The PRISTINE registry is a follow up to the encouraging results seen in the PRESTIGE clinical trial (Below The Knee, Chronic Limb Threatening Ischemia) at 6 months.